![Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet](https://www.thelancet.com/cms/attachment/2000995621/2003688051/gr1.jpg)
Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet
![Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma | SpringerLink Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40487-020-00113-5/MediaObjects/40487_2020_113_Fig1_HTML.png)
Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma | SpringerLink
![Children | Free Full-Text | Neuroblastoma: Tumor Biology and Its Implications for Staging and Treatment Children | Free Full-Text | Neuroblastoma: Tumor Biology and Its Implications for Staging and Treatment](https://www.mdpi.com/children/children-06-00012/article_deploy/html/images/children-06-00012-g001.png)
Children | Free Full-Text | Neuroblastoma: Tumor Biology and Its Implications for Staging and Treatment
Problems of Neuroblastoma Screening for 6 Month Olds and Results of Second Screening for 18 Month Olds
![Genome-scale CRISPR–Cas9 screening identifies selective neuroblastoma... | Download Scientific Diagram Genome-scale CRISPR–Cas9 screening identifies selective neuroblastoma... | Download Scientific Diagram](https://www.researchgate.net/publication/327119015/figure/fig1/AS:731590279827515@1551436123737/Genome-scale-CRISPR-Cas9-screening-identifies-selective-neuroblastoma-gene-dependencies.png)
Genome-scale CRISPR–Cas9 screening identifies selective neuroblastoma... | Download Scientific Diagram
![Analysis of Neuroblastoma Mortality Rates before and after the Cessation of the Mass Screening Program According to Vital Statistics of Japan Data Analysis of Neuroblastoma Mortality Rates before and after the Cessation of the Mass Screening Program According to Vital Statistics of Japan Data](https://www.omicsonline.org/articles-images/epidemiology-mass-screening-7-305-g005.png)